Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by 이권선, Chief Executive Officer. Officer active across 2 companies, notably 셀바이오휴먼텍. Aggregated, 39 disclosures have been published. History available since 10 March 2026. The latest transaction was filed on 1 April 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Lee Gwon-seon is the CEO of Cellbio Human Tech, an innovative company in the biotechnology sector. He is responsible for the strategic direction and management of operations. His leadership is essential for the development and growth of the company.